Logo image of CRL.MI

CAREL INDUSTRIES SPA (CRL.MI) Stock Fundamental Analysis

Europe - BIT:CRL - IT0005331019 - Common Stock

22.1 EUR
+0.2 (+0.91%)
Last: 11/13/2025, 11:07:09 AM
Fundamental Rating

5

Overall CRL gets a fundamental rating of 5 out of 10. We evaluated CRL against 20 industry peers in the Building Products industry. CRL gets an excellent profitability rating and is at the same time showing great financial health properties. CRL is valied quite expensively at the moment, while it does show a decent growth rate. These ratings could make CRL a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year CRL was profitable.
CRL had a positive operating cash flow in the past year.
CRL had positive earnings in each of the past 5 years.
Each year in the past 5 years CRL had a positive operating cash flow.
CRL.MI Yearly Net Income VS EBIT VS OCF VS FCFCRL.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 7.29%, CRL belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
CRL has a Return On Equity of 14.29%. This is in the better half of the industry: CRL outperforms 75.00% of its industry peers.
With a decent Return On Invested Capital value of 8.69%, CRL is doing good in the industry, outperforming 70.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CRL is in line with the industry average of 10.55%.
Industry RankSector Rank
ROA 7.29%
ROE 14.29%
ROIC 8.69%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
CRL.MI Yearly ROA, ROE, ROICCRL.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

CRL's Profit Margin of 10.34% is amongst the best of the industry. CRL outperforms 85.00% of its industry peers.
CRL's Profit Margin has been stable in the last couple of years.
Looking at the Operating Margin, with a value of 11.63%, CRL belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
CRL's Operating Margin has declined in the last couple of years.
CRL has a Gross Margin of 45.73%. This is comparable to the rest of the industry: CRL outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of CRL has grown nicely.
Industry RankSector Rank
OM 11.63%
PM (TTM) 10.34%
GM 45.73%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
CRL.MI Yearly Profit, Operating, Gross MarginsCRL.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

CRL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, CRL has about the same amount of shares outstanding.
The number of shares outstanding for CRL has been increased compared to 5 years ago.
Compared to 1 year ago, CRL has an improved debt to assets ratio.
CRL.MI Yearly Shares OutstandingCRL.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
CRL.MI Yearly Total Debt VS Total AssetsCRL.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 5.46 indicates that CRL is not in any danger for bankruptcy at the moment.
CRL's Altman-Z score of 5.46 is amongst the best of the industry. CRL outperforms 85.00% of its industry peers.
The Debt to FCF ratio of CRL is 1.66, which is an excellent value as it means it would take CRL, only 1.66 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of CRL (1.66) is better than 95.00% of its industry peers.
CRL has a Debt/Equity ratio of 0.21. This is a healthy value indicating a solid balance between debt and equity.
CRL's Debt to Equity ratio of 0.21 is fine compared to the rest of the industry. CRL outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.66
Altman-Z 5.46
ROIC/WACC1.12
WACC7.79%
CRL.MI Yearly LT Debt VS Equity VS FCFCRL.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

CRL has a Current Ratio of 1.58. This is a normal value and indicates that CRL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.58, CRL is in line with its industry, outperforming 50.00% of the companies in the same industry.
CRL has a Quick Ratio of 1.13. This is a normal value and indicates that CRL is financially healthy and should not expect problems in meeting its short term obligations.
CRL has a Quick ratio of 1.13. This is in the better half of the industry: CRL outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.13
CRL.MI Yearly Current Assets VS Current LiabilitesCRL.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

5

3. Growth

3.1 Past

The earnings per share for CRL have decreased strongly by -19.15% in the last year.
The Earnings Per Share has been growing by 9.70% on average over the past years. This is quite good.
The Revenue has decreased by -2.99% in the past year.
CRL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 12.06% yearly.
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%50.45%
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%9.42%

3.2 Future

CRL is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.70% yearly.
The Revenue is expected to grow by 8.49% on average over the next years. This is quite good.
EPS Next Y-5.43%
EPS Next 2Y6.6%
EPS Next 3Y9.7%
EPS Next 5YN/A
Revenue Next Year6.98%
Revenue Next 2Y8.17%
Revenue Next 3Y8.49%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CRL.MI Yearly Revenue VS EstimatesCRL.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CRL.MI Yearly EPS VS EstimatesCRL.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 39.46, which means the current valuation is very expensive for CRL.
Compared to the rest of the industry, the Price/Earnings ratio of CRL indicates a slightly more expensive valuation: CRL is more expensive than 65.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. CRL is valued slightly more expensive when compared to this.
CRL is valuated quite expensively with a Price/Forward Earnings ratio of 34.73.
65.00% of the companies in the same industry are cheaper than CRL, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 34.43. CRL is around the same levels.
Industry RankSector Rank
PE 39.46
Fwd PE 34.73
CRL.MI Price Earnings VS Forward Price EarningsCRL.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CRL's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. CRL is more expensive than 85.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRL is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 28.66
EV/EBITDA 22.78
CRL.MI Per share dataCRL.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

The decent profitability rating of CRL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.07
EPS Next 2Y6.6%
EPS Next 3Y9.7%

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.77%, CRL is not a good candidate for dividend investing.
CRL's Dividend Yield is slightly below the industry average, which is at 2.15.
Compared to an average S&P500 Dividend Yield of 2.36, CRL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.77%

5.2 History

On average, the dividend of CRL grows each year by 14.04%, which is quite nice.
Dividend Growth(5Y)14.04%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

30.38% of the earnings are spent on dividend by CRL. This is a low number and sustainable payout ratio.
CRL's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP30.38%
EPS Next 2Y6.6%
EPS Next 3Y9.7%
CRL.MI Yearly Income VS Free CF VS DividendCRL.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CRL.MI Dividend Payout.CRL.MI Dividend Payout, showing the Payout Ratio.CRL.MI Dividend Payout.PayoutRetained Earnings

CAREL INDUSTRIES SPA

BIT:CRL (11/13/2025, 11:07:09 AM)

22.1

+0.2 (+0.91%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-01 2025-08-01
Earnings (Next)11-13 2025-11-13
Inst Owners26.81%
Inst Owner ChangeN/A
Ins Owners52.75%
Ins Owner ChangeN/A
Market Cap2.49B
Revenue(TTM)593.19M
Net Income(TTM)61.32M
Analysts72
Price Target24.17 (9.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.77%
Yearly Dividend0.19
Dividend Growth(5Y)14.04%
DP30.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.67%
Min Revenue beat(2)-5.31%
Max Revenue beat(2)-2.03%
Revenue beat(4)0
Avg Revenue beat(4)-3.4%
Min Revenue beat(4)-5.31%
Max Revenue beat(4)-1.82%
Revenue beat(8)2
Avg Revenue beat(8)-2.93%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.34%
PT rev (3m)8.55%
EPS NQ rev (1m)-13.33%
EPS NQ rev (3m)-13.33%
EPS NY rev (1m)-1.26%
EPS NY rev (3m)-3.53%
Revenue NQ rev (1m)-4.94%
Revenue NQ rev (3m)-4.94%
Revenue NY rev (1m)-0.75%
Revenue NY rev (3m)-1.41%
Valuation
Industry RankSector Rank
PE 39.46
Fwd PE 34.73
P/S 4.19
P/FCF 28.66
P/OCF 21.78
P/B 5.79
P/tB 42.18
EV/EBITDA 22.78
EPS(TTM)0.56
EY2.53%
EPS(NY)0.64
Fwd EY2.88%
FCF(TTM)0.77
FCFY3.49%
OCF(TTM)1.01
OCFY4.59%
SpS5.27
BVpS3.81
TBVpS0.52
PEG (NY)N/A
PEG (5Y)4.07
Graham Number6.93
Profitability
Industry RankSector Rank
ROA 7.29%
ROE 14.29%
ROCE 10.92%
ROIC 8.69%
ROICexc 10.39%
ROICexgc 34.66%
OM 11.63%
PM (TTM) 10.34%
GM 45.73%
FCFM 14.62%
ROA(3y)8.19%
ROA(5y)8.54%
ROE(3y)21.17%
ROE(5y)23.44%
ROIC(3y)11.78%
ROIC(5y)12.59%
ROICexc(3y)15.05%
ROICexc(5y)17.4%
ROICexgc(3y)43.53%
ROICexgc(5y)43.91%
ROCE(3y)14.8%
ROCE(5y)15.83%
ROICexgc growth 3Y-17.51%
ROICexgc growth 5Y-0.61%
ROICexc growth 3Y-24.29%
ROICexc growth 5Y-10.93%
OM growth 3Y-8.96%
OM growth 5Y-3.73%
PM growth 3Y-2.46%
PM growth 5Y0.24%
GM growth 3Y2.57%
GM growth 5Y4.66%
F-Score6
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.66
Debt/EBITDA 0.83
Cap/Depr 66.97%
Cap/Sales 4.62%
Interest Coverage 15.41
Cash Conversion 103.86%
Profit Quality 141.48%
Current Ratio 1.58
Quick Ratio 1.13
Altman-Z 5.46
F-Score6
WACC7.79%
ROIC/WACC1.12
Cap/Depr(3y)91.98%
Cap/Depr(5y)87.52%
Cap/Sales(3y)4.87%
Cap/Sales(5y)4.61%
Profit Quality(3y)86.55%
Profit Quality(5y)91.31%
High Growth Momentum
Growth
EPS 1Y (TTM)-19.15%
EPS 3Y5.31%
EPS 5Y9.7%
EPS Q2Q%50.45%
EPS Next Y-5.43%
EPS Next 2Y6.6%
EPS Next 3Y9.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y11.23%
Revenue growth 5Y12.06%
Sales Q2Q%9.42%
Revenue Next Year6.98%
Revenue Next 2Y8.17%
Revenue Next 3Y8.49%
Revenue Next 5YN/A
EBIT growth 1Y-15.06%
EBIT growth 3Y1.26%
EBIT growth 5Y7.88%
EBIT Next Year86.33%
EBIT Next 3Y32.51%
EBIT Next 5YN/A
FCF growth 1Y46.46%
FCF growth 3Y14.88%
FCF growth 5Y15.64%
OCF growth 1Y34.27%
OCF growth 3Y16.42%
OCF growth 5Y11.49%

CAREL INDUSTRIES SPA / CRL.MI FAQ

What is the fundamental rating for CRL stock?

ChartMill assigns a fundamental rating of 5 / 10 to CRL.MI.


Can you provide the valuation status for CAREL INDUSTRIES SPA?

ChartMill assigns a valuation rating of 1 / 10 to CAREL INDUSTRIES SPA (CRL.MI). This can be considered as Overvalued.


How profitable is CAREL INDUSTRIES SPA (CRL.MI) stock?

CAREL INDUSTRIES SPA (CRL.MI) has a profitability rating of 7 / 10.


What is the valuation of CAREL INDUSTRIES SPA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for CAREL INDUSTRIES SPA (CRL.MI) is 39.46 and the Price/Book (PB) ratio is 5.79.


How financially healthy is CAREL INDUSTRIES SPA?

The financial health rating of CAREL INDUSTRIES SPA (CRL.MI) is 7 / 10.